Antimicrobial Susceptibility Testing Market 2022 Growing Incidence Of Infectious Diseases

According to Precision Business Insights (PBI), latest report, the antimicrobial susceptibility testing market is expected to be valued at USD 3,645.3 million in 2022, growing at a 6.2% CAGR from 2022 to 2028. The primary driver of the expansion of the global Antimicrobial Susceptibility Testing market is the rising incidence of infectious diseases and the emergence of multidrug resistance across the globe.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/antimicrobial-susceptibility-testing-market/

Clinical Diagnostics Segment to Dominate the Antimicrobial Susceptibility Testing Market:
The clinical diagnostics segment is estimated to generate a large revenue share in the Antimicrobial Susceptibility Testing market. It is expected to have a significant growth rate during the forecasted period owing to the rising problem of antibiotic resistance, increasing prevalence of HAIs, the growing procedural volume of clinical diagnostic tests, rising emphasis on effective and early disease diagnosis among major markets, and rising awareness among physicians about Antimicrobial Susceptibility Testing testing methods. Clinical diagnostic tests provide accuracy to identify a particular disease, which in turn this test creates an opportunity among key players to make more technologically advanced clinical diagnostics in lesser time, consequently expanding the market of Antimicrobial Susceptibility Testing.

North America Antimicrobial Susceptibility Testing Market:
North America is expected to have a significant growth rate in the global Antimicrobial Susceptibility Testing testing market over the forecast period, due to the better healthcare infrastructure and continuous advancement in developing new drugs. Moreover, the increasing launches of products. For example, in 2021, Accelerate Diagnostics, Inc., an in vitro diagnostics company, announced the launch of a new IVD (In vitro diagnostic) configuration of its Accelerate Pheno Test BC kit in the U.S. With this launch, the company now provides two solutions for fast sepsis testing. These launches of varieties of diagnostics tests will expand the market for Antimicrobial Susceptibility Testing.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Antimicrobial Susceptibility Testing market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In April 2022, BIOMÉRIEUX, a multinational biotechnology company, announced that it signed an agreement to acquire Specific Diagnostics, a privately held U.S.-based company that has developed a rapid Antimicrobial Susceptibility Testing test (AST) system, specific revealing Rapid AST system that delivers phenotypic AST directly from positive blood cultures.

View the detailed report description here - https://precisionbusinessinsights.com/request-sample?product_id=58720

The antimicrobial susceptibility testing market is segmented based on product type, type, method, application, end user, and geography.
Based on the product type, the market is segmented into the following:
• Manual Antimicrobial Susceptibility Testing Testing Products
• Automated Laboratory Instruments
• Culture and Growth Media
• Consumables

Based on the type, the market is segmented into the following:
• Antibacterial Susceptibility Testing
• Antifungal Susceptibility Testing
• Antiparasitic Susceptibility Testing
• Other Susceptibility Testing Types (slow-growing pathogens)

Based on the method, the market is segmented into the following:
• Etest Method
• Disk Diffusion
• Automated Susceptibility Testing Instruments
• Agar Dilution
• Genotyping Methods

Based on the application, the market is segmented into the following:
• Clinical Diagnostics
• Drug Discovery and Development
• Epidemiology
• Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)

Based on the end user, the market is segmented into the following:
• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Research & Academic Institutes
• Clinical Research Organizations (CROs)

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=58720

Key players' profiles in the antimicrobial susceptibility testing market report are Accelerate Diagnostics, Inc., Becton, Dickinson, and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Bruker Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche AG, HiMedia Laboratories, Merck KGaA (MilliporeSigma), and Thermo Fisher Scientific.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.